John P. Butler
Board Member
Akebia Therapeutics, Inc. (AKBA)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About John P. Butler
John P. Butler is recorded as CEO and Board Member at Akebia Therapeutics, Inc. (AKBA). Akebia Therapeutics, Inc. reported in an 8-K filed June 13, 2025 that John P. Butler was appointed Class II director, effective June 10, 2025. The proxy statement of Akebia Therapeutics, Inc. reports total compensation of $5,652,339 for John P. Butler in fiscal 2025, including a base salary of $864,010. Disclosed compensation is on record for 5 fiscal years.
“The proposal to elect two Class II directors, John P. Butler and Myles Wolf, M.D., M.M.Sc., to serve until the 2028 annual meeting of stockholders and until their successors are duly elected and qualified, subject to their earlier death, resignation or removal was approved as follows:”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2025-06-10–present
-
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Akebia Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- John Butler CEO, CFO, Board Member
- Ellen Snow CFO
- Erik Ostrowski CFO
- David A. Spellman Chief Accounting Officer
- Richard C. Malabre Chief Accounting Officer
- Adrian Adams Board Member
- LeAnne M. Zumwalt Board Member
- Michael Rogers Board Member
- Myles Wolf, M.D., M.M.Sc. Board Member
- Myles Wolf, M.D., M.S.Sc. Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Akebia Therapeutics, Inc. (AKBA) | President and Chief Executive Officer — | $864,010 | $5,652,339 |
| 2024 | Akebia Therapeutics, Inc. (AKBA) | President and Chief Executive Officer | $833,966 | $4,260,114 |
| 2023 | Akebia Therapeutics, Inc. (AKBA) | President and Chief Executive Officer | $795,723 | $2,775,123 |
| 2022 | Akebia Therapeutics, Inc. (AKBA) | President and Chief Executive Officer | $765,118 | $3,072,538 |
| 2021 | Akebia Therapeutics, Inc. (AKBA) | President and Chief Executive Officer | $718,430 | $3,133,316 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.